Category Archives: Health

Elysium Health: The Blue Pill that Could Change Lives

Elysium Health under the leadership of MIT biologist Leonard Guarente broadcasted that it will work to convert chemicals that increase mice and worms lifespan in the laboratory into an OTC vitamin pill that individuals can ingest to hopefully receive similar effects.

According to Dr. Guarantee, it is difficult to prove the workings of the new drug within a reasonable time frame as such test could take many years. For this reason, the biologist has decided to use an alternative route of wrapping the pioneering lab research into nutraceuticals since they do not require any clinical testing or approval by FDA.

The blue pill created by Elysium Health is known as ‘Basis.’ The pill contains the chemical nicotinamide adenine dinucleotide (NAD), a compound that is allegedly used up by cells to perform metabolic functions such as the release of energy from glucose. The compound is presumed to bring on similar effects to a diet that is short on calories- a proven mechanism to increase a mouse life’s span.

This new approach by biologist Guarente has never been previously used before in the industry, and the doctor plans on marketing the molecules to be used as dietary supplements after which he will follow up with the clients over time to see how they function.

Elysium decided to sell its pill only on its website and conducted its marketing on social media. By December 2016, Basis was priced at $50 per month or a $60 one-time purchase while the two active ingredients could be bought separately at $25.

Elysium Health partnered with several leading scientists, medical practitioners, and clinicians including prominent scientists to ensure that it develops the original and promising natural compound.

Karplus, a lecturer at Harvard, in a telephone interview explained that he was turning 85 and that he was interested in trying Basis as soon as it is ready. Dr. Guarente, who is 62, also takes the pill daily along with a 25 mg of resveratrol and the red-wine compound. Moreover, the biologist also exercises even though not consistently as he would like.https://www.youtube.com/watch?v=y1AIrm58m10

Leonard Guarente is not troubled by the fact that there still no apparent gains resulting from the intake of this supplement as it will likely take time to reveal any real benefits.

About Elysium Health

Elysium Health is a biotechnology firm with its headquarters in New York and was established in 2014 by MIT biologist Leonard Guarente alongside Eric Marcotuli who is the company’s CEO and Dan Alminana, the Chief Operating Officer. In 2015, Elysium began retailing Basis as a dietary supplement as it contained Nicotinamide riboside and pterostilbene in one capsule. According to the firm, the two supplements assisted in making nicotinamide adenine dinucleotide (NAD) that may have  helped some cellular processes.

By December 2016, Elysium had managed to raise $26.2 million from its investors such as General catalyst and Robert Nelson of ARCH Venture Partners. For more inquiries about basis contact Elysium on (888)220-6436, M-F or visit their website at elysiumhealth.com.

Getting Ready for a Life Line Screening

There are many ways to learn about what may be going on with your body. Life Line Screening is one way to do that. You should do a few things so you are ready for the testing that you will get at the screening.

Choose Your Tests

These tests all take different things and depending on the test, you will need to prepare in different ways. You should choose your testing well before the date to know what you need to do. If you are doing a test that makes it where you can’t eat, you will need to follow the directions stop eating at a certain time so the testing will be accurate. You may also need to just relax before the testing, but you should wear clothing that is loose and comfortable.

Don’t Stress About the Tests

Once the day gets there, don’t stress about the tests you are going to be doing. These tests are simple and usually very painless. The most you will have to do is go through a needle prick to take some blood. That will be the worst of it. There is no reason to worry about the testing or be afraid of what you will find out. By taking these tests, you are getting information that could save your life.

After the Tests

After you have done the tests, relax and get some good food. If you weren’t able to eat while you were waiting for the testing, then this would be the best time to take break and eat. You want to take it easy for a little while before you get back to your normal routine. You should be fine the next day, but if you don’t feel quite right yet, take another day to make sure you are in top shape.

There are many ways you can get this information, but doing these screenings about health treatment and knowing ahead of time will give you are chance to know what it happening with you. The last thing you want is to get sick and not know until it was too late.

Learn More: www.lifelinescreening.com/Global/Employee-Access

Eric Lefkofsky’s Architype for Data Driven Healthcare

Many hear the name Eric Lefkofsky and think entrepreneurial kingpin. By co-founding companies like Groupon, Echo Global Logistics, and Uptake Technologies, he created a foundation of success in the world of tech startup companies. Now worth $1.7 billion according to Forbes, it may seem like he’s exited the world of company building and entered a life led by less involved endeavors.

Eric Lefkofsky statement would have been true, but then his wife Liz was diagnosed with breast cancer. A tumultuous time under the best of circumstances, Eric and Liz were baffled by the lack of comprehensive data to help develop treatments plans best suited for individual patients. Soon after Liz’s diagnosis, Lefkofsky took his degree from the University of Michigan and doctoral degree from the University of Michigan Law School and started one last company, Tempus.

Tempus still holds true to the nature of many of Lefkofsky’s other companies in that it is a data driven tech company. However, it isn’t geared towards local commerce or marketing. The goal of Tempus is to create a wheelhouse of data from doctors from some of the nation’s leading medical institutions. The startup established connections with the Mayo Clinic, the University of Chicago, Northwestern University, and the University of Michigan. Oncologists at these facilities send their patients to Tempus where they are then sequenced in Tempus’ lab. This data is stored and then each patient is paired up with cancer clinical information that matched their molecular profile. This comprehensive data is then sent back to the attending oncologist so that they can utilize whatever methods are most ideal for any individual nuances of that patient’s pathology to learn more: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html click here.

This chain of events may seem like Tempus is a medical company, however, at the end of the day, it is still a tech company. It is merely driven by medical data in order to create a hub for cancer treatment methods and access. The impact for a company like Tempus will take years to see fully fulfilled. However, when those results reveal themselves, the impact will likely be life saving for millions.

Medical Publishing with Oncotarget

Oncotarget is a medical journal, which is peer-reviewed on a weekly basis, covering research papers on all dimensions of oncology. The medical journal was instituted in 2010, and Impact Journals did the publishing. The journal has two chief editors, Mikhail Blagosklonny and Andrei v. Gudkov from the Roswell Park Cancer Institute.

Mikhail Blagosklonny is an Associate Editor of Therapy and Cancer Biology, a member of Cell Death and Differentiation, Editorial Board and an Editor In Chief of Oncotarget, Ageing of Cells and Cell Cycle Journals. He is a professor of Oncology at the esteemed Roswell Park Cancer Center in Buffalo, New York. Roswell Park is one the institutions that offer comprehensive cancer treatment.

Visit ResearchGate to keep up to date with Mikhail’s latest work.

Oncotarget is a multidisciplinary journal featuring free access. The Journal posts the peer-reviewed papers every week. Additionally, each issue of the journal may be printed on special demand. The mission of the Oncotarget is to make scientific research results and papers rapidly and widely available. This is with the aim of maximizing the impact of research, as well as allowing discoveries to be shared instantly. By eliminating the border between the specialties, Oncotarget strived to link up the different fields in the biomedical sciences.

Under the leadership tenure of elite scientists, Oncotarget assists researcher add to the progress and growth of science. The journal’s primary goal is for people to live healthy, free from any diseases. Currently, Oncotarget offers free alt-metric reports for articles to provide real-time tracking of medical articles in both traditional and digital media platforms on Facebook. Furthermore, to the benefit of researchers and other scientists, Oncotarget is soon launching sections, in addition to oncology. Such additional categories include cardiology, endocrinology, immunology, pharmacology, MoI Biology and neuropathology cell among others.

The editors at Oncotarget are tasked with the responsibility of evaluating manuscripts on merit, quality of data, scientific novelty, and presentation regardless of the author’s citizenship, race, religious affiliations, and sexual orientation. The decision to publish a medical article is not founded on political policies and other agencies, rather the journal itself. The chief editors have the authority over all the editorial content of the journal even during the time of publishing.

The editorial staff is required not to disclose any information regarding the manuscripts to anyone other than the authors, reviewers, members of the editorial board and potential reviewers. Editors are additionally not allowed to utilize an unpublished material for other purposes but are required to keep the information confidential. The editorial team assesses the manuscripts without significant conflicts of interests stemming from collaborative, competitive, as well as other connections with the respective authors.

View Mikhail’s profile on Loop.

The Story of the Trio that founded Sweetgreen

When college students graduate, most of them have a mentality that they will land a job in a big company. This is not always the case. As witnessed in the recent past, many graduates are increasingly finding themselves stranded after completing their education. With many qualified candidates having to compete for the few jobs that the economies have to offer, many graduates are stranded unable to secure their dream jobs.

 

Many graduates end up working in fields and geographical areas they never thought or visualized themselves in. They are forced by situations to either accept to fill the available job positions or start private ventures.

 

When three Washington students, Jonathan Neman, Nicolas Jammet, and Nathaniel Ru, graduated from college, they decided to seek the help of friends and families in starting a venture named Sweetgreen.

 

In an interview, they said that they somehow felt that their fate would lead them to run their own business since neither of them had much interest in employment. The desire to build and run their own business and the need to provide better food choices to their society led to the birth of Sweetgreen.

 

 Jonathan Neman, Nicolas Jammet, and Nathaniel Ru had no idea that a few years down the line they would have a brand that is nationally recognized and adored by many. The trio credits their success to hard work and dedication to their goals.

 

Most of their investors were brought aboard by the spirit of the trio to succeed. The investors put their money in the startup because its founders’ business plan was precise and clear. The investors also acknowledged the commitment of the trio toward implementing the plan to the letter.

 

Sweetgreen was first established in Washington DC where the founders opened their iconic pioneer restaurant in 2007. Since then, they have expanded to other American cities and as at January 2016, they have over 30 retail locations.

 

Sweetgreen operates as a casual restaurant where people can walk in and order simple, healthy meals. The restaurant also offers seasonal meals themed from select regional cuisines. Their food products are grown organically.

 

Nathaniel Ru serves alongside his co-founders as the company’s CEO. He has served in this capacity for over nine years. He is fluent in both Spanish and English, which gives him an edge when negotiating international deals.